Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating cytokine-treated veto cells as an adoptive therapy after stem cell transplantation for various hematolog…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Evaluation of Pediatric eCART Implementation [NA]
A clinical trial update on evaluating a pediatric eCART implementation, sponsored by the University of Wisconsin, Madison, currently recruit…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies [Phase 1]
Phase 1 clinical trial update for LV009 injection in hematologic and lymphoid cancers, including Non-Hodgkin Lymphoma and Acute Lymphoblasti…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment [Phase 3]
Update on a Phase 3 clinical trial evaluating individualized, targeted, and intensified therapy for adults with newly diagnosed acute lympho…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia
An update on a clinical trial evaluating natural killer cell therapy for monitoring patients with acute myeloid leukemia, acute lymphoblasti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) [Phase 1, Phase 2]
The first-in-human study of SAR443579 in children and adults with relapsed or refractory acute myeloid leukemia, acute lymphoblastic leukemi…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: CD22 Redirected Autologous T Cells for ALL [Phase 1]
Phase 1 clinical trial update on autologous T cells redirected to CD22 for B-cell leukemias and lymphomas, sponsored by the University of Pe…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant
An ongoing clinical trial investigating muscle dysfunction in patients with hematologic diseases referred for stem cell transplantation.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: BESPONSA Injection 1 mg Special Investigation
Completed clinical trial evaluating BESPONSA (inotuzumab ozogamicin) 1 mg for acute lymphoblastic leukemia; results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma [Phase 2, Phase 3]
Clinical trial update for Total Therapy XVII in newly diagnosed acute lymphoblastic leukemia and acute lymphoblastic lymphoma, spanning Phas…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Cellular Immunotherapy in Treating Patients With High-Risk Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 clinical trial evaluating cellular immunotherapy for high-risk B-cell acute lymphoblastic leukemia, with status listed as active but…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
A prospective registry study collecting diagnosis, treatment, and outcome data for adults with acute lymphoblastic leukemia and related dise…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Pharmacogenomics of Asparaginase Induced Hepatotoxicity
A clinical trial update describes ongoing pharmacogenomic research into factors that influence asparaginase-induced hepatotoxicity in acute …
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors [Phase 2]
Phase 2 study evaluating exercise training with nicotinamide riboside (NR) supplementation to improve fitness in adolescent/young adult hema…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: CD19-CD22-Bispecific Chimeric Antigen Receptor (CAR) T Cell Therapy for Pediatric Patients With Acute Lymphoblastic Leukemia [Phase 1]
This clinical trial update reports on a Phase 1 study of a CD19-CD22 bispecific CAR-T cell therapy for pediatric acute lymphoblastic leukemi…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Evaluation of the Efficacy of a Virtual Reality When Placing a Needle on an Implantable Venous Access Device in Children With Leukemia [NA]
A clinical trial is evaluating whether virtual reality can reduce anxiety and discomfort during needle placement for implantable venous acce…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: A Multicenter Study of CAR-T Cells in Primary Ph+All [Phase 2]
A multicenter Phase 2 clinical trial evaluating CAR-T cell therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia is curr…
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate
This update reports that the ItaliaN observational study of patients with Acute Lymphoblastic Leukemia treated with an anti-CD22 immunoconju…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes [NA]
A recruiting clinical trial sponsored by The University of Texas at Arlington is evaluating virtual reality–infused treadmill training and i…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia
This update describes a clinical trial evaluating a dose-adjusted regimen for frail adults withacute lymphoblastic leukemia. It aims to asse…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML [Phase 1, Phase 2]
This clinical trial update describes pediatric patients with relapsed/refractory CD19+ acute lymphoblastic leukemia and diffuse large B-cell…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML [Phase 1]
A Phase I study of the selective nuclear export inhibitor KPT-330 (selinexor) in children with relapsed or refractory acute lymphoblastic le…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: A Multicenter, Open-Label, Non-Randomized, Single-Arm Clinical Study of Nanobody CD5-CAR T Cell Therapy for Refractory/Relapsed T Lymphocyte Malignancies [Phase 1, Phase 2]
A multicenter Phase 1/2 open-label, single-arm study evaluating nanobody-based CD5-CAR T cell therapy for relapsed/refractory T-cell maligna…
-
CLINICAL_TRIALS research · 2025-11-26Clinical Trial Update: Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating autologous and donor-derived CD7 CAR-T cell therapy for refractory or relapsed T-cell malignancies,…
-
CLINICAL_TRIALS other · 2025-11-26Clinical Trial Update: Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies [NA]
Clinical trial update for Miltenyi Biomedicine's cell and gene therapy program indicates ongoing recruitment and planned long-term follow-up…